Zhong Ji Longevity Science (HKG:0767) forecasts it will swing to a loss of between HK$32 million and HK$35 million in 2024 from a profit of HK$2.3 million in 2023, according to a Wednesday filing with the Hong Kong bourse.
The financial and longevity science research company attributes the foreseen loss to one-off legal and service fees of HK$20.4 million, as well as marketing expenses, and material restructuring costs, the filing said.
Zhong Ji Longevity Science expects to release full-year results on or before March 28.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。